How does Sword Health differentiate itself from other digital MSK providers?

The deck emphasizes three main differentiators: 100% of care is delivered by licensed physical therapists, their sensor technology is 4x more accurate than human observation, and they possess a massive IP moat, owning 70% of all digital MSK patents. They also highlight a broader range of treated joints compared to competitors, including new wrist therapies.

What are the key clinical outcomes reported in the deck?

Sword Health reports significant clinical improvements: a 70% reduction in pain, a 64% reduction in surgery intent, and a 48% reduction in medication consumption. Additionally, they cite a 52% decrease in depression and a 35% decrease in anxiety among patients, alongside a 32% increase in workplace productivity.

Who is the target customer for Sword Health?

While the deck mentions insurers and health systems, the primary focus is on self-funded employers. Slide 4 notes that MSK care is the top cost for 85% of these employers. By reducing surgery intent and improving productivity, Sword positions itself as a high-ROI benefit for corporate HR and benefits departments.

What is missing from the Sword Health pitch deck?

The deck is notably missing a specific 'Ask' slide detailing how much capital is being raised and the intended use of funds. It also lacks a detailed slide on unit economics (LTV/CAC) and a formal three-to-five-year financial projection, which are standard for many venture decks, though common to omit in high-level overview versions.

Sword Health Pitch Deck (2015): 19-Slide Breakdown

See all 19 slides of the Sword Health pitch deck — a 2015 Later deck — with a slide-by-slide teardown of what the deck does well and where it falls short.

Sword Health’s pitch deck is a highly effective example of how to sell a complex health-tech solution by focusing on clear market pain points and superior clinical outcomes. The deck establishes urgency by showing that musculoskeletal (MSK) costs now exceed cancer and mental health spending combined. It then positions Sword as the only 'clinical-grade' virtual solution, backed by proprietary sensor technology that is 4x more accurate than the human eye. With a reported 8x revenue growth from 2020 to 2021 and a 9/10 patient satisfaction rating, the deck balances aggressive growth metrics with…

Key takeaways

Musculoskeletal conditions cost more to treat than cancer and mental health combined, according to slide 3.
MSK care is the #1 cost for 85% of self-funded employers, as shown on slide 4.
Sword Health claims its sensor-based technology is up to 4x more accurate than the human eye (slide 10).
The company owns 70% of all digital MSK patents, covering over 200 movements (slide 10).
Sword reported an 8x increase in revenue from 2020 to 2021 (slide 17).
Patient outcomes include a 70% reduction in pain and a 64% reduction in surgery intent (slide 15).
The treatment completion rate for Sword is 89%, compared to just 30% for traditional physical therapy (slide 14).
The deck highlights a global presence with launches in Europe (2015), Australia (2018), and the US (2019) on slide 7.

Introduction: The High Stakes of Musculoskeletal Care

Sword Health entered the market in 2015 with a mission to solve one of the most expensive problems in healthcare: musculoskeletal (MSK) pain. This teardown examines the 19-slide deck that helped the company secure a total of $323.5 million in funding. The deck is a masterclass in establishing market urgency, proving technical superiority, and validating results through hard clinical data. It moves quickly from the 'why' to the 'how,' positioning the company not just as a software play, but as a clinical-grade medical intervention.

Slides 1-4: Establishing the Problem and Market Urgency

The deck opens with a clean title slide featuring Founder and CEO Virgilio Bento, PhD. The inclusion of the PhD title immediately signals that this is a science-led organization. Slide 2 uses a powerful visual comparison, showing a physical therapy clinic in 1960 alongside one in 2020. The caption, 'THE WAY WE TREAT MUSCULOSKELETAL PATIENTS HAS NOT CHANGED IN THE LAST 60 YEARS,' highlights a stagnant industry ripe for disruption.

Slide 3 provides the economic 'shock' factor. It features a line graph showing that per capita expenditures for MSK conditions have climbed to approximately $600, surpassing both Cancer and Mental Health. The slide explicitly states that we spend more on MSK than Cancer and Mental Health combined. Slide 4 narrows the focus to the buyer: self-funded employers. It notes that MSK is the #1 cost for 85% of these employers and is the fastest-growing expense category. By the end of slide 4, the investor is convinced that the problem is massive, expensive, and underserved.

Slides 5-7: The Sword Health Solution and Global Footprint

Slide 5 introduces the mission: 'Free two billion people from chronic and post-surgical musculoskeletal pain.' This is an incredibly ambitious 'North Star' metric that sets the scale of the company's vision. Slide 6 serves as a transition, defining the category as 'Clinical-grade Musculoskeletal care made virtual.' The use of the term 'clinical-grade' is a deliberate jab at 'wellness' or 'fitness' apps that lack medical rigor.

Slide 7 provides a 'Snapshot of SWORD Health,' showing their global expansion. It lists their founding in Europe (2015), entry into Australia (2018), and the United States (Dec 2019). The slide is adorned with regulatory logos, including FDA, HIPAA, HITRUST, SOC2, and CE/GDPR. This builds immediate trust, showing that the company has already cleared the significant legal and regulatory hurdles required to operate in major global markets.

Slides 8-11: Technology and The 'IP Moat'

This section explains why Sword is better than its competitors. Slide 8 breaks the solution into three pillars: Licensed Physical Therapists, Sensor-based tech, and universal joint coverage. Slide 9 emphasizes the 'Human Touch,' noting that 100% of care is delivered by Doctors of Physical Therapy (DPTs) with an average of 4.5 years of prior experience. This counters the fear that 'virtual' means 'automated' or 'low-quality.'

Slide 10 is perhaps the most important slide for a technical investor. It claims the technology is 'Up to 4x more accurate than the human eye.' More importantly, it states that 'SWORD owns 70% of all digital MSK patents,' enabling them to track over 200 different movements. This represents a massive barrier to entry for competitors. Slide 11 uses a donut chart to show the distribution of therapies across the body, highlighting that Sword covers areas like the shoulder (21%) and neck (11%) that competitors often struggle to treat effectively. It also introduces a new 'Wrist' therapy for 2021.

Slides 12-16: Outcomes and Patient Validation

After explaining the tech, the deck moves to results. Slide 12 and 16 feature patient testimonials from 'Sara' and 'Arthur,' adding a human element to the data. Slide 14 focuses on engagement, a key metric for digital health. It shows an 89% treatment completion rate for Sword, compared to 73% for other digital solutions and a dismal 30% for traditional physical therapy. A standout stat on this slide is that '1 in 2 members did their exercises on Christmas Day 2020,' proving extreme user stickiness.

Slide 15 delivers the clinical 'knockout' punch with six key metrics: a 70% reduction in pain, 64% reduction in surgery intent, 48% reduction in medication consumption, 52% reduction in depression, 35% reduction in anxiety, and a 32% increase in productivity. By showing that MSK treatment improves mental health and work performance, Sword justifies its premium positioning to employers.

Slides 17-19: Growth, Team, and Conclusion

Slide 17 shifts to business performance. It highlights an '8x increase in revenue from 2020 to 2021' and notes that 2 million+ digital PT minutes were delivered in 2020. This demonstrates that the company is no longer in the 'experiment' phase but is scaling rapidly. Slide 18 introduces the team, which is a 'who's who' of digital health and tech giants. Leaders come from Virta Health, Clover Health, Airbnb, Uber, and Rally Health. This gives investors confidence that the management team has the experience to handle hyper-growth.

The deck concludes on slide 19 with a simple 'Thank You' and contact information for the CEO. Notably, there is no slide asking for a specific dollar amount, which is common for companies in 'Later' stages (as identified in the catalogue facts) where the deck serves more as a high-level introduction or a leave-behind for a pre-negotiated round.

What Works in This Deck

The IP Moat: Stating that you own 70% of the patents in your space (Slide 10) is a powerful way to shut down questions about competition. · Comparative Economics: Comparing MSK costs to Cancer and Mental Health (Slide 3) immediately re-frames the size of the opportunity for investors who might otherwise view physical therapy as a niche market. · Clinical Rigor: The constant use of terms like 'Clinical-grade' and 'Doctors of Physical Therapy' separates Sword from the crowded field of wellness apps. · Engagement Data: The 'Christmas Day' stat (Slide 14) is a memorable anecdote that proves the product is actually being used, which is the biggest hurdle in digital health.

What is Missing from This Deck

The Ask: There is no slide detailing how much money is being raised or what the specific milestones for the next 18-24 months are. · Unit Economics: While revenue growth is mentioned, there is no mention of Customer Acquisition Cost (CAC), Lifetime Value (LTV), or gross margins. · Competitive Landscape: While they mention 'competitors' on slide 11, they don't name them or provide a feature-by-feature comparison matrix. · Financial Projections: The deck looks backward at 2020 and 2021 but does not provide a forward-looking roadmap for hitting profitability or specific revenue targets.

What a Founder Should Copy

The 'Problem' Visuals: Use side-by-side historical comparisons (like Slide 2) to show why the current status quo is outdated. · Regulatory Badging: If you have FDA or HIPAA compliance, put those logos front and center (Slide 7). It acts as a 'permission to play' in healthcare. · Outcome-First Storytelling: Don't just say your tech works; show the specific percentage reductions in pain and surgery intent (Slide 15). · Team Pedigree: If your team comes from successful unicorns, list their former titles clearly (Slide 18). It transfers the credibility of those established brands to your startup.

Frequently asked questions

What is Sword Health's core value proposition?: Sword Health provides clinical-grade virtual musculoskeletal (MSK) care. Unlike competitors that may rely solely on video or chat, Sword uses proprietary wearable sensors and licensed Doctors of Physical Therapy (DPTs) to provide real-time feedback and personalized treatment. This approach aims to reduce the need for surgeries, imaging, and opioids while lowering costs for employers.
How does Sword Health differentiate itself from other digital MSK providers?: The deck emphasizes three main differentiators: 100% of care is delivered by licensed physical therapists, their sensor technology is 4x more accurate than human observation, and they possess a massive IP moat, owning 70% of all digital MSK patents. They also highlight a broader range of treated joints compared to competitors, including new wrist therapies.
What are the key clinical outcomes reported in the deck?: Sword Health reports significant clinical improvements: a 70% reduction in pain, a 64% reduction in surgery intent, and a 48% reduction in medication consumption. Additionally, they cite a 52% decrease in depression and a 35% decrease in anxiety among patients, alongside a 32% increase in workplace productivity.
Who is the target customer for Sword Health?: While the deck mentions insurers and health systems, the primary focus is on self-funded employers. Slide 4 notes that MSK care is the top cost for 85% of these employers. By reducing surgery intent and improving productivity, Sword positions itself as a high-ROI benefit for corporate HR and benefits departments.
What is missing from the Sword Health pitch deck?: The deck is notably missing a specific 'Ask' slide detailing how much capital is being raised and the intended use of funds. It also lacks a detailed slide on unit economics (LTV/CAC) and a formal three-to-five-year financial projection, which are standard for many venture decks, though common to omit in high-level overview versions.

Cover slide of the Sword Health pitch deck — Later 2015 — Sword Health pitch deck, slide 1 (2015)

Sword Health pitch deck: the facts

Company: Sword Health
Year: 2015
Stage: Later
Slides: 19
Sector: Digital Health / Musculoskeletal (MSK)
Deck type: Pitch Deck
Outcome: $323,500,000 Raised
Headquarters: New York City, USA (and Porto, Portugal)

Sword Health pitch deck PDF

The full Sword Health deck is embedded on this page and can be read slide by slide in the browser — no download or account required. Each slide is covered in the breakdown above.

What the Sword Health pitch deck was used for

This is Sword Health’s 19‑slide pitch deck from around 2015, used when the company was emerging as a digital health provider focused on virtual musculoskeletal (MSK) care. The deck positions Sword Health as a clinical‑grade, sensor‑based virtual physical therapy platform targeting employers and health plans burdened by high MSK costs. It emphasizes patient outcomes, proprietary sensor technology and licensed physical therapists to show how the solution could disrupt the large MSK market and underpin the company’s subsequent venture funding rounds. Public commentary on the deck links it to the fundraising trajectory that led to more than $323M in capital raised over the following years, but individual round specifics are documented in later press releases rather than tied explicitly to this deck.

Business model: Sword Health provides virtual musculoskeletal (MSK) care using proprietary wearable sensor technology combined with licensed Doctors of Physical Therapy (DPTs) to deliver clinical-grade remote physical therapy and rehabilitation.

Investors: Seed investors including European venture funds and angel investors in 2018, Khosla Ventures as Series A lead investor, Additional Series A extension investors including Founders Fund, Green Innovations, Lachy Groom, Vesalius Biocapital and, Later‑stage investors in Series B, C and D rounds including General Catalyst, BOND, Highmark Ventures, Sapphire Ventures
Founded: 2015
Founders: Virgílio Bento
Headquarters: New York, United States
Industry: Digital Health / Virtual Musculoskeletal (MSK) Care

Round: Later stage by the time cumulative funding exceeded $300M, though the deck dates to an earlier commercialization phase when the company was proving its model to early investors.

Year: The deck is from around 2015; documented funding rounds associated with the company’s growth include a 2018 seed round, a 2019–2020 Series A and multiple later rounds through 2021.

Raising: The 2015 deck itself is described in public commentary as part of the story that helped Sword Health ultimately secure over $323M in funding, but the exact target amount and valuation for the specific raise tied to this deck are not disclosed.

Raised: Documented primary rounds include a $4.6M seed (2018), $17M total Series A (2019–2020), $25M Series B (2021), $85M Series C (2021) and $163M Series D (2021), with subsequent financing lifting total funding above $320M.

Lead investor: Khosla Ventures led the initial $8M Series A round; Sapphire Ventures led the later $163M Series D.

Total funding: Approximately $323–340M in total funding raised across seed, Series A, B, C, D and later financing rounds by 2024–2025, as reported by company communications and industry press.

Use of funds as presented: Across documented rounds, Sword Health stated that funds would be used to further develop its digital therapy platform, expand into the U.S. market, grow employer and health plan relationships, enhance technology and AI capabilities, and scale operations in virtual MSK care.

What happened after the Sword Health deck

Sword Health has evolved from an early virtual musculoskeletal care innovator using sensor‑based technology and licensed PTs into a later‑stage digital health company backed by substantial venture funding and strategic investors, achieving significant scale and valuations while continuing to focus on reducing MSK costs for employers and improving patient outcomes.

Founded in 2015 and developed a sensor‑based virtual physical therapy platform for musculoskeletal conditions.
Raised a $4.6M seed round in April 2018 to advance its digital therapy system.
Closed an $8M Series A in April 2019 led by Khosla Ventures, later extended to $17M with additional investors, to expand
Secured a $25M Series B in early 2021 to expand access to digital MSK care and scale employer and health plan relationsh
Raised an $85M Series C in mid‑2021, followed by a $163M Series D, reaching around a $2B valuation as one of the fastest
Subsequent financing rounds brought total funding above $320M, reinforcing its position as a leading virtual MSK provide

What the Sword Health deck got right

Compelling problem sizing with comparative cost data. The deck clearly quantifies the MSK problem by stating that current spending on musculoskeletal conditions exceeds spending on cancer and mental health combined and by showing per‑capita expenditure data, which gives investors an immediate sense of the market’s size and urgency.
Direct link between clinical problem and employer cost burden. It highlights that musculoskeletal care is the number‑one and fastest‑growing cost for self‑funded employers, tying the clinical issue directly to a high‑value economic buyer and reinforcing the relevance to employer health benefits strategies.
Differentiated, comprehensive virtual MSK solution. Sword Health positions its solution as the most complete offering in virtual MSK, combining sensor‑based technology, real‑time feedback and licensed physical therapists delivering 100% of care, which differentiates it from simpler telehealth or app‑only competitors.
Broad clinical coverage with personalized care plans. The deck emphasizes that the system treats all major joints for both chronic pain and post‑surgical rehab, and that licensed PTs adjust programs multiple times per week, suggesting strong personalization and coverage across a wide range of MSK conditions.
Integrated multidisciplinary care model (PT, behavioral, CBT). By spotlighting licensed Doctors of Physical Therapy, therapeutic exercise, behavioral coaching and cognitive behavioral therapy as integrated components, the deck presents a multi‑disciplinary, evidence‑informed care model likely to resonate with clinically savvy investors.
Strong technology and clinical insight positioning. Claims such as real‑time sensor feedback more accurate than human eyes and insights like members receiving prescriptions for areas different from where they feel pain highlight both technological sophistication and clinical insight, which can support a narrative of superior care quality.

What could have been stronger

Limited commercial and go‑to‑market detail. The deck leans heavily on broad cost claims such as musculoskeletal spend exceeding cancer and mental health combined and MSK being the top cost for self‑funded employers, but based on the partial slide text there is limited detail on specific target segments, pricing, or go‑to‑market mechanics (e.g., sales cycle length, channel strategy, or employer adoption metrics), which can leave investors uncertain about how the model scales commercially.
Clinical evidence and regulatory validation not fully visible. While the deck asserts that Sword’s sensor‑based tech is more accurate than human eyes and that licensed PTs deliver 100% of care, the partial slides do not show rigorous clinical trial data, regulatory status, or detailed methodology supporting these claims, which could be a concern for investors focused on healthcare evidence and compliance.
Sparse early traction metrics in the visible content. The deck emphasizes employer cost burden and clinical outcomes but, in the available text, provides little quantitative traction such as current revenue, number of covered lives, active employer customers or utilization rates at that time, which makes it harder for investors to assess product‑market fit beyond the qualitative story.
Operational scalability and provider economics not clearly detailed. Although the deck highlights licensed DPTs and behavioral/coaching components, the partial slides do not clarify how Sword manages provider capacity, staffing economics, or quality assurance at scale, which may leave open questions about margins and operational scalability.

How an investor would read this deck

What draws attention

Clear articulation that musculoskeletal conditions represent a larger spend than cancer and mental health combined, positioning MSK as a massive, under‑served cost driver for health systems and employers.
Strong fit between the product (sensor‑based virtual physical therapy with licensed PTs) and a well‑defined pain point for self‑funded employers whose top and fastest‑growing cost category is MSK care.
Differentiation from telehealth competitors by combining proprietary wearable sensors with real‑time feedback and 100% of care delivered by Doctors of Physical Therapy, enhancing the perceived defensibility.
Inclusion of behavioral coaching and cognitive behavioral therapy elements alongside therapeutic exercise, suggesting a comprehensive, multidisciplinary approach that could improve adherence and outcomes.
Mission‑driven framing (freeing billions of people from chronic and post‑surgical MSK pain) paired with claims of strong clinical outcomes, which can support both impact and financial theses.

Risks that stand out

Dependence on employers and health plans as primary buyers means that long enterprise sales cycles and budget constraints could slow growth, especially if MSK solutions are viewed as discretionary benefits.
Reliance on licensed Doctors of Physical Therapy for 100% of care may create scaling constraints or cost pressures if automation and remote monitoring cannot sufficiently offset clinician labor costs.
If the clinical and economic outcome claims (e.g., reductions in pain and surgery intent) are not backed by strong evidence or fail to replicate across broader populations, employers may question ROI and churn.
Competitive risk from other virtual MSK and digital physical therapy platforms that may offer lower‑cost or more automated solutions, potentially pressuring pricing and employer choice.
Regulatory or data‑privacy changes affecting remote monitoring, wearable sensors, or telehealth reimbursement could impact Sword Health’s operating model and margin structure.

Questions this deck invites

What specific clinical studies, outcome metrics, and peer‑reviewed evidence support the claims about pain reduction, surgery intent reduction, and sensor accuracy relative to human eyes at the time of this deck?
How many employers, health plans, or health systems were contracting with Sword Health when this deck was used, and what were the typical contract sizes, pricing models, and retention rates?
What regulatory and reimbursement pathways did Sword Health rely on (e.g., FDA considerations, CPT codes, employer wellness budgets), and how were these navigated in 2015–2018?
How scalable is the care delivery model that uses licensed DPTs for 100% of treatment, and what are the unit economics (provider cost per member, gross margin per episode, and impact of automation via sensors and software)?
How defensible is Sword Health’s technology stack and IP portfolio in the digital MSK space, and how do competitors’ offerings compare on sensors, clinical oversight, and outcomes?

What founders can take from the Sword Health deck

Anchoring the narrative in a massive, clearly quantified cost category (musculoskeletal spend exceeding cancer and mental health combined) helps investors quickly understand the scale and urgency of the problem.
Showing that MSK care is the number‑one and fastest‑growing cost for self‑funded employers connects the clinical problem directly to a compelling economic buyer, strengthening the business case.
Combining proprietary hardware (wearable sensors) with licensed clinical providers (DPTs) and behavioral/coaching components illustrates a differentiated, full‑stack approach rather than a generic telehealth app, which can support defensibility.
Emphasizing that 100% of care is delivered by licensed PTs and that sensor‑based tech provides real‑time feedback more accurate than human eyes communicates quality and clinical rigor in a virtual setting.
Positioning virtual MSK care as “clinical‑grade made virtual” and integrating chronic and post‑surgical pain in one platform shows how a startup can frame digital health offerings as replacements for traditional care rather than mere add‑ons.
Highlighting specific outcome metrics (such as pain reduction and changes in surgery intent) makes the deck more persuasive than relying solely on theoretical benefits, especially in healthcare markets.

Sword Health pitch deck: common questions

What does Sword Health do?

Sword Health is a digital health company that delivers clinical‑grade virtual musculoskeletal (MSK) care using proprietary wearable sensors and licensed Doctors of Physical Therapy (DPTs) to treat chronic and post‑surgical pain remotely.

What is notable about Sword Health’s 2015 pitch deck?

The available commentary describes a 19‑slide Sword Health pitch deck from around 2015 that introduced its virtual MSK platform, highlighted the high cost burden of musculoskeletal conditions, and showed how sensor‑based technology and licensed PTs could deliver clinical‑grade remote care.

Which funding round did Sword Health’s 19‑slide deck help raise?

Commentary on the deck states that this 19‑slide presentation helped Sword Health demonstrate how clinical‑grade virtual care could disrupt the musculoskeletal market and was part of the fundraising story that led to more than $323M in total capital raised, but public sources do not assign the deck to a single specific round such as the 2018 seed or 2019 Series A.

How much funding has Sword Health raised since using this deck?

Later press releases show that Sword Health raised a $4.6M seed round in April 2018, an $8M Series A in April 2019 (later extended to $17M), a $25M Series B in early 2021, an $85M Series C in mid‑2021 and a $163M Series D that brought its valuation to about $2B, plus a subsequent financing that lifted total funding above $320M; these rounds collectively are linked in public commentary to the success of the original 19‑slide deck.

How does Sword Health’s pitch deck frame the problem and its solution for employers?

The deck stresses that musculoskeletal conditions cost more than cancer and mental health combined, and that MSK care is the number‑one and fastest‑growing cost for self‑funded employers. Sword Health’s virtual MSK solution, combining sensors and licensed PTs, is presented as a way for employers and health plans to reduce these costs while improving outcomes.

Sources

Funding and outcome facts on this page were researched on 2026-08-21 from the pages below.

Sword Health pitch deck slides

Sword Health pitch deck slide 1 of 19 — Sword Health pitch deck — slide 1 of 19

Sword Health pitch deck slide 2 of 19 — Sword Health pitch deck — slide 2 of 19

Sword Health pitch deck slide 3 of 19 — Sword Health pitch deck — slide 3 of 19

Sword Health pitch deck slide 4 of 19 — Sword Health pitch deck — slide 4 of 19

Sword Health pitch deck slide 5 of 19 — Sword Health pitch deck — slide 5 of 19

Sword Health pitch deck slide 6 of 19 — Sword Health pitch deck — slide 6 of 19

What each slide of the Sword Health pitch deck says

Slide 3

And right now we spend more money treating Musculoskeletal conditions than Cancer and Mental Health combined' Per capita expenditures in US $ by disease categaory

Slide 4

Musculoskeletal care alone is the #1 cost for self-funded employers - and the fastest growing. * Top Condition & Second Condinien Thed Conditien Mussuloskelatal = 85% T4 Large Emplayers' Top Conditions Impacting Health Care Costs, 2019

Slide 5

Te Enter SWORD Health wall i — » Fae Missi ‘@ R ssion Li | Free two billion people from chronic and . post-surgical musculoskeletal pain. pE—"— = ———

Slide 8

SWORD is the most complete solution in the virtual MSK space = ree 4 W P » it L hrhie Wil Physical Therapists Sensor-based tech Works for everyone SWORD uses licensed Gives real-time feedback Treats all the major joints, PTs to deliver 100% of the that's more accurate than for chronic pain and human care. human eyes post-surgical rehab

Slide 9

The Human Touch delivered by Licensed PTs Therapeutic Behavioral exercise coaching Clinical Cognitive education behavioral therapy 100% of care by DPTs 4.5 years of prior experience N 12% = of SWORD members get a prescription for a different area than where they eel pain % 2-4 times a week - SWORD PT' programs "s adjust members'

Slide text above is read directly from the Sword Health deck PDF embedded on this page.